In breast cancer, for example, the hotspot AKT1 E17K mutation occurs in only about 3% of primary breast cancers; however, that gene is an important part of the PI3-kinase-AKT-mTOR pathway, which is frequently mutated in breast cancer [7]. This evidence concerns the gene MTOR and breast cancer.